KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Staar Surgical (STAA) Cash & Equivalents (2016 - 2026)

Staar Surgical (STAA) has disclosed Cash & Equivalents for 17 consecutive years, with $153.2 million as the latest value for Q1 2026.

  • For the quarter ending Q1 2026, Cash & Equivalents rose 6.24% year-over-year to $153.2 million, compared with a TTM value of $153.2 million through Jan 2026, up 6.24%, and an annual FY2026 reading of $153.2 million, up 6.24% over the prior year.
  • Cash & Equivalents was $153.2 million for Q1 2026 at Staar Surgical, down from $176.2 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $224.0 million in Q1 2024 and bottomed at $86.5 million in Q4 2022.
  • Average Cash & Equivalents over 5 years is $156.3 million, with a median of $165.6 million recorded in 2024.
  • The sharpest move saw Cash & Equivalents plummeted 56.7% in 2022, then skyrocketed 149.0% in 2024.
  • Year by year, Cash & Equivalents stood at $86.5 million in 2022, then skyrocketed by 111.65% to $183.0 million in 2023, then decreased by 21.24% to $144.2 million in 2024, then grew by 22.19% to $176.2 million in 2025, then decreased by 13.06% to $153.2 million in 2026.
  • Business Quant data shows Cash & Equivalents for STAA at $153.2 million in Q1 2026, $176.2 million in Q3 2025, and $167.1 million in Q2 2025.